Keefe, Bruyette & Woods Forecasts Strong Price Appreciation for Crescent Capital BDC (NASDAQ:CCAP) Stock

Crescent Capital BDC (NASDAQ:CCAP) had its price objective lifted by equities researchers at Keefe, Bruyette & Woods from $19.00 to $20.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price target points to a potential upside of 3.79% from the company’s current price.

A number of other research firms have also issued reports on CCAP. Bank of America reduced their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 15th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 target price for the company. Finally, Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $19.17.

Crescent Capital BDC Stock Up 0.5 %

Shares of NASDAQ:CCAP opened at $19.27 on Monday. The firm’s 50-day moving average is $18.56 and its two-hundred day moving average is $18.51. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. Crescent Capital BDC has a 1 year low of $15.91 and a 1 year high of $19.63. The firm has a market capitalization of $714.15 million, a PE ratio of 7.56 and a beta of 0.81.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CCAP. Point72 Asset Management L.P. acquired a new stake in shares of Crescent Capital BDC during the 2nd quarter worth about $90,000. XTX Topco Ltd acquired a new stake in Crescent Capital BDC during the second quarter worth approximately $195,000. Catalina Capital Group LLC purchased a new stake in shares of Crescent Capital BDC during the 2nd quarter worth approximately $220,000. Cubist Systematic Strategies LLC acquired a new position in shares of Crescent Capital BDC in the 2nd quarter valued at $346,000. Finally, Van ECK Associates Corp grew its position in shares of Crescent Capital BDC by 136.1% in the 2nd quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock valued at $498,000 after buying an additional 15,288 shares during the last quarter. 49.46% of the stock is owned by institutional investors and hedge funds.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.